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Abstract
Background: Dedifferentiation occurs naturally in mature cell types during epimorphic regeneration in fish and
some amphibians. Dedifferentiation also occurs in the induction of pluripotent stem cells when a set of
transcription factors (Oct4, Sox2, Klf4 and c-Myc) is over expressed in mature cell types.
Results: We hypothesised that there are parallels between dedifferentiation or reprogramming of somatic cells to
induced pluripotent stem cells and the natural process of dedifferentiation during epimorphic regeneration. We
analysed expression levels of the most commonly used pluripotency associated factors in regenerating and non-
regenerating tissue and compared them with levels in a pluripotent reference cell. We found that some of the
pluripotency associated factors (oct4/pou5f1, sox2, c-myc, klf4, tert, sall4, zic3, dppa2/4 and fut1, a homologue of
ssea1) were expressed before and during regeneration and that at least two of these factors (oct4, sox2) were also
required for normal fin regeneration in the zebrafish. However these factors were not upregulated during
regeneration as would be expected if blastema cells acquired pluripotency.
Conclusions: By comparing cells from the regeneration blastema with embryonic pluripotent reference cells we
found that induced pluripotent stem and blastema cells do not share pluripotency. However, during blastema
formation some of the key reprogramming factors are both expressed and are also required for regeneration to
take place. We therefore propose a link between partially reprogrammed induced pluripotent stem cells and the
half way state of blastema cells and suggest that a common mechanism might be regulating these two processes.
Background
Differentiation during development is normally viewed
as a one way process from undifferentiated to more dif-
ferentiated cells. However, some lower vertebrates such
as teleost fish and some amphibians are able to compen-
sate for the loss of body parts by regenerating a nearly
perfect copy of the original part by dedifferentiating
cells in vivo to facilitate regeneration.
After the loss of an appendage undifferentiated, pluri-
or multipotent cells from different origins accumulate at
the damaged surface to form a regeneration blastema.
The blastema is formed after wound closure through
dedifferentiation of at least three terminally differen-
tiated cell types, fibroblasts [1], keratinocytes [2] and
myotubes [3]. Endogenous stem cells like muscle satel-
lite cells also seem to provide cells for the blastema [4].
Despite the heterogeneous origin of the blastema cells,
histologically they appear as a homogeneous population
of cells and therefore have been traditionally viewed as a
single cell type. This view however has been recently
challenged [5]. After blastema formation, a period of
extensive proliferation of blastema cells follows, before
the cells re-differentiate to produce all the different cell
types for the tissues of the missing appendage.
In contrast, it only recently became possible to dedif-
ferentiate or reprogram somatic cells to pluripotent cells
in vitro [6]. Exposure to just four transcription factors
(most commonly Oct4, Sox2, c-Myc and Klf4) is enough
to reprogram fibroblasts and many other differentiated
cell types into induced pluripotent stem (iPS) cells
[7-11]. This raises the question whether the in vivo ded-
ifferentiation or reprogramming seen during regenera-
tion has similarities to the in vitro reprogramming of
fibroblasts to iPS cells.
We noticed that two of the reprogramming factors
were expressed during Xenopus limb regeneration.
Furthermore, a recent publication presented evidence
that the reprogramming factors c-myc, sox2 and klf4
were expressed during regeneration in newts [12].
Therefore we thought to investigate the similarities and
differences on a more systematic and broader scale.
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any medium, provided the original work is properly cited.In this paper we explore the possibility of similarities
between reprogramming and regeneration from a mole-
cular point of view. We chose two of the current regen-
eration models, zebrafish and Xenopus for this purpose.
Each model offers different opportunities and techniques
that add to the general picture of blastema cell forma-
tion. In particular we concentrated on caudal fin regen-
eration in zebrafish and limb and tail regeneration in
Xenopus. While these three structures are very different
anatomically it has been shown that the underlying
molecular mechanism of regeneration is very similar
[13-18], therefore conservation of the differentiation sta-
tus of the blastema cells of these three appendages is as
well expected. We focused on the studies of gene
expression by quantitative real time polymerase chain
reaction (qPCR) of regenerating and non-regenerating
tissue compared to an embryonic, pluripotent reference
cell type, analysis of the blastema cell cycle by fluores-
cence-activated cell sorting (FACS) and a functional
approach by knocking down pou5f1/oct4 and sox2 with
morpholinos in the zebrafish caudal fin demonstrating
that some of the core factors needed for reprogramming
are present and required during regeneration.
Results
Expression of pluripotency associated markers
To determine whether there are any similarities between
in vivo regeneration and reprogramming of fibroblast
cells to iPS cells we made two assumptions. First, we
treated the blastema as a homogeneous population of
cells, as would be predicted if they dedifferentiated to a
pluripotent state and second, we expected overall levels
of pluripotency associated factors to increase as abun-
dance of blastema cells increases up to a comparable
expression level of a pluripotent reference cell.
To assess the differentiation status of blastema cells a
panel, consisting of zebrafish and Xenopus homologues
of the genes most commonly used to characterize
mouse or human ES and iPS cells, was put together.
The panel includes the four most commonly used repro-
gramming factors oct4 (pou class 5 homoeobox1,a l s o
called pou5f1), sox2 (sex determining region Y box 2),
klf4 (kruppel-like factor 4), c-myc (proto-oncogene myc)
as well as sall4 (sal-like4), lin28, a1, 3/4 fucosyltransfer-
ase lewis1 (Fut1) which is the homologue of stage-speci-
fic embryonic antigen-1 (ssea1) and others (See Table 1).
The panel, however, does not include nanog,am a i n
player for pluripotency acquisition [19], since no homo-
logue has been described either in zebrafish or Xenopus.
For oct4, four homologues have been described in Xeno-
pus (oct25, oct60, oct79 and oct91) and it has been
s h o w nf o rt h r e eo ft h e mt h a tt h e yc a nr e s c u et h ep h e -
notype of an oct4
-/- knockout mouse embryonic stem
(ES) cell line [20].
We first tested the panel of genes in a cell type repre-
senting the closest to a pluripotent cell type in these
species. Since neither Xenopus nor zebrafish ES cell cul-
tures have been properly established [21] we used cells
from early developmental stages of both species.
For Xenopus, animal cap cells were chosen as the
pluripotent cell type, as these cells are able to differenti-
ate into many different cell types of all three germ layers
in culture by over-expressing specific genes or by cultur-
ing the caps in different conditions [22,23].
All but two of the pluripotency associated markers
tested in Xenopus were expressed in the animal cap cells
indicating that a similar gene core network might be
operational during early amphibian development to con-
fer pluripotency (Figure 1A) to that found in the main-
tenance of pluripotency of mouse or human ES/iPS cells
[24-27]. The exceptions were Fut1, the homologue of
ssea1,a n doct91 which did not show expression above
the rt
- control. (The results for oct25, oct60 and oct79
were combined as oct4 in Figure 1A-1C since they all
showed similar expression profiles while oct91 was left
out of Figure 1A-1C)
To cover the complete process of Xenopus limb and
tail regeneration we chose four discrete time points that
represent different stages of regeneration to assess the
differentiation status of blastema cells: non-regenerating
tissue (0 day post amputation (dpa)), blastema formation
(1 dpa), blastema expansion (3 dpa) and blastema redif-
ferentiation (5 dpa). If cells acquired pluripotency during
regeneration one could expect to see an increase in
pluripotency associated markers either during blastema
formation (1 dpa) or blastema expansion (3 dpa). Since,
Xenopus loses the capacity to regenerate its limbs during
metamorphosis (stage (st) 56 to 63) [28,29], we included
regenerative incompetent limbs at st57 as a further con-
trol in our study.
The expression profile of the same factors in Xenopus
blastema cells showed some differences to animal cap
cells. Out of 11 factors tested only six or seven were
expressed in a limb or tail blastema, respectively and
each of these factors was also expressed in both non-
regenerating limbs (0 dpa) and regenerative incompetent
limbs (st57) (Figure 1A-1C).
Of these seven genes, four (zic3, tert-A, dppa2/4,
sall4) were expressed at lower levels in the blastema
than in pluripotent cells, while sox2 and c-myc,t w oo f
the factors facilitating reprogramming, and Fut-1,a n
early marker in the reprogramming process, were
e x p r e s s e da ts i m i l a ro rh i g h e rl e v e l s .N o te x p r e s s e d
above rt
- control were the homologues of oct4 (oct25,
oct60, oct79, oct91), lin28, cripto3 and gdf3 (Figure 1A
and 1B).
Furthermore, none of the factors tested was upregu-
lated during limb regeneration. However, some tissue
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Two of the factors, sall4 and Fut1, displayed modest
upregulation during tail blastema formation, but no sta-
tistically significant upregulation during limb regenera-
tion even though both factors showed a similar
expression wave over time in tail and limb regeneration.
(see Figure 1B and 1A). To our surprise we also found
some upregulation of sox2, c-myc and Fut1 in regenera-
tive incompetent pseudo blastemas of st57 limbs that
peaked at 1 dpa and dropped back to expression levels
of non-regenerating (0 dpa) limbs by 3 dpa. Since this
peak of expression was not seen with all the genes
tested, we assumed that it is biologically real and not
caused by a technical error. Furthermore, sall4 is also
significantly upregulated at 3 dpa and 5 dpa in the
regenerative incompetent limbs (Figure 1C). We do not
know what the significance of these expression peaks
are, however they are certainly not relevant for pluripo-
tency in these regenerative incompetent pseudo blaste-
mas. A similar early peak of sox2 expression has also
Table 1 Gene panel.
Gene GenBank Acc no function Primer F Primer R
Zebrafish
pou5f1 NM_131112,1 pluripotency, homolog of mammalian Oct4 GGTTCGGAAGCCCAGGATT TGAGCTGAGGGAATGTTTTGC
sox2 NM_213118,1 pluripotency ACCCCGGAGGAAAACCAA CCCGGCAGGGTGTACTTG
zic3 NM_001001950,2 pluripotency CCCTGGGCTGGGACTCA CTTGAAGGCAGCCGAGTGA
klf4 NM_131723 pluripotency GAACCACTGCGGGCAAAT GATGGTGGAGTCAGCATCACA
c-myc L11710 pluripotency CGTCAACGCGGCATGA GATTGTTGCTAGCCTCAAGTCGTA
sall4 NM_001080609 Sall4 activates Pou5f1 expression in vivo and
in vitro
CTCCCAGAGACCTTCTTCATCAG GACCGAACATGCCAGAAGAAA
tert NM_001083866 pluripotency, downregulation of TERT
caused loss of pluripotency and human ESC
differentiation
CGACAGCAAACCGAAAAAACTT CGACTGAATAGCGGCACCAT
mps1 (or
tkk)
NM_175042 blastemal proliferation TGGATGGTTCGCTGAAGCTAA GGTCACGTCAGGCTGAATCTG
hsp60 NM_181330 fin regeneration GGTGAGGACGGCACTGCTA TTCAGCGGTGGACAAGAGAGA
Msxb NM_131260 regulate the rate of proliferation of blastema
cells during fin regeneration
CCAGCAGGTCGCGTGTTC TCCTGACCATGTCCCATTCTC
hsp90a1 NM_131328 mouse Es cells TGAACTGATCCCAGACCAGAAA CAATGCCGGTGTCGATGAT
Xenopus
oct25 M60074 homolog of mammalian Oct4 CCCCAATGTTTCAGGCTTGT CCACAGGCCGTGCAGACT
oct60 M60075 homolog of mammalian Oct4 CAGAAACACAGCCGGACAGA CACCCATAGCAGCACAGCAT
oct79 M60076 homolog of mammalian Oct4 CACGACCTGACCTCCTGGTATAC TGCTGGACCTCCATTAATATTGC
oct91 M60077 homolog of mammalian Oct4 AACGTGACCTCGATTTGCACTA AACGTGACCTCGATTTGCACTA
sox2 NM_001088222 pluripotency GCACATGTCGCAACACTATCAGA GGCAGCGTGCCATTGATC
c-myc X56870 pluripotency GGCGGAACGAGCTTAAGTTG CGCCACCTCGGGTACCT
lin28 NM_001087449 pluripotency GCCCAGTGTCCAGAGAAAGC TCCTCAGTGATTGGCTGATCTTC
zic3 NM_001087619 pluripotency TGCCAGCTCAGGGTACGAAT TCCTCACTGTTGGCAGAAACC
tert-A NM_001085633 pluripotency, homolog of human htert ATATTCTTGCTTCAAGCTTACAGGTTT CCGCTGGCCAAATGGA
cripto3 AJ864901 pluripotency, homolog of TDGF3 GGAAGATATTGCGAGCTTCATGT CAATGGCCATGTGGAACAATT
gdf3 NM_001087497 pluripotency GCTGTTTTACAGACTCTGGTGCAT GGGCACAGCAAGGCAATG
sall4 AY336983 pluripotency AGTTCATTGTGCCTCCTACAGTCA CGCGGTGGCATACTGGTT
dppa2/4 NM_001096099 pluripotency, hypothetical protein equally
homolog to dppa2 and dppa4
TGTGACGAGTGTTTTGAGAGGAA AGACCGACCTCTGCTGCAA
Fut1 AY278679 pluripotency, a1,3/4 fucosyl transferase lewis
1, mouse homolog of ssea1
TGCCACCTTACGAACTTTCTCA AATCTGTCCCGTTTCACTTTGC
msx1 BC081101 blastema marker GAGAAAGCACAAAACCAACAGAAA GGCCAGCAGTTGGGATGTAG
fgf8 NM_001090435 blastema marker CGACCCACACGCCAAGTTA TTTAATGCGAACTCTGCTTCCA
lef1 NM_001096734 blastema marker CCCACTGTCCCCAGGAAGT GTGGATACCAGCCCAATGGT
ODC NM_001086698.1 housekeeping gene TCCATTGAGAGCGTAGGACTTG GAGGCTCGCCGGTGAAATA
Forward and reverse primers used in quantification of relative expression by qPCR of zebrafish and Xenopus genes. Gene names and accession numbers are
specified as well as gene function.
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lens regeneration in newts [12].
To test the quality of our dataset, three other genes
that have been described as blastema markers (msx1,
fgf8 and lef1), were tested and showed the expected
upregulation of expression during the first 5 dpa (Figure
1E) giving us confidence in the quality of the dataset
[13,30-32].
Other studies have reported sox2 and c-myc expres-
sion in newt lens and limb regeneration [12]. While
these authors report upregulation of the two factors in
newt limbs, we did not see a significant change in
expression levels during regeneration in Xenopus. More-
over, the two factors were also expressed in regenerative
incompetent limbs in Xenopus,w i t hc-myc being
expressed at much higher levels in the older limb than
in the younger, regenerative competent limb.
For zebrafish, embryos at the oblong blastula stage (3
2/3 hpf at 28.5°C) were chosen to represent the pluripo-
tent cell type since this stage is considered optimal to
try to derive zebrafish ES cells [33]. These blastula
derived cells have been shown to be able to contribute
towards the germ line if injected into zebrafish embryos
and therefore to be pluripotent [34].
In accordance, we found that all eight pluripotency
related genes tested were expressed in these blastula
cells (Figure 1D and Additional file 1), with three of
them (pou5f1, klf4, sall4)e x p r e s s e da ts i g n i f i c a n t l y
higher levels than in early regenerating fin cells. The
other five genes (s o x 2 ,c - m y c ,t e r t ,z i c 3 ,h s p 9 0 a )w e r e
expressed at low levels, both in the embryonic cells and
in non-regenerating fin, with only sox2 showing signifi-
cantly higher expression in fin than in embryonic cells
(Figure 1D). We noticed, though, much higher sox2
expression in a slightly younger blastula stage (unpub-
lished result) but not in oblong stage.
In agreement with results obtained in Xenopus,n o n e
of the eight pluripotency associated markers tested
showed any upregulation during wound healing (6 h),
blastema formation (24 h, 48 h) or blastema outgrowth
(72 h). Intriguingly, pou5f1 was not completely shut
down in adult fins and was also expressed in the
Figure 1 qPCR of a pluripotent cell type compared with cells of the regeneration blastema. A) Relative expression of pluripotency
associated genes in Xenopus cap cells compared to limb blastema (st52) at different time points during regeneration. In red is relative
expression of animal cap cells, in green the relative expression of st52 limb blastemas at 0 dpa, 1 dpa, 3 dpa and 5 dpa. (note: the results for
oct25, oct60 and oct79 expression was combined as oct4 expression). B) Relative expression of pluripotency associated genes in Xenopus cap
cells and st52 tail blastema cells. C) Relative expression of pluripotency associated genes in Xenopus cap cells and regenerative incompetent
pseudo blastemas of st57 limbs at 0 dpa, 1 dpa, 3 dpa, and 5 dpa. Asterisks indicate significant (P < 0.05) upregulation of expression compared
to 0 dpa. D) Relative gene expression for pluripotency associated markers in zebrafish non-regenerating (0 hpa), regenerating (6 hpa to 72 hpa)
fin and embryonic cells in oblong stage. E) Relative expression of blastema markers in cap cells and regenerating limbs. Asterisks indicate
significant (P < 0.05) upregulation of gene expression compared to the previous time point. F) Relative expression of blastema markers in
zebrafish non-regenerating (0 hpa), regenerating (6 hpa to 72 hpa) fin and embryonic cells in oblong stage. For each gene, expression was
normalized to highest expressing tissue. Error bars indicate Standard deviation (SD). (For statistical differences see Additional file 1).
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either newts or Xenopus ([12], this paper). Some of the
fin blastema markers were unexpectedly highly
expressed also at oblong stage (Figure 1F).
These results demonstrate that expression of pluripo-
tency associated genes alone does not indicate pluripo-
tency of that cell, since all of these genes are also
expressed in differentiated cells of the limb, tail and fin
at similar levels.
To make sure we did not miss any relevant gene in
our panel, we investigated the relative expression of
pluripotency associated genes in previously published
microarray data sets from regenerating Xenopus limbs
and cap cells and zebrafish caudal fin (see Methods).
We found good agreement with our qPCR results in
that the relative expression of pluripotency associated
markers was generally higher in animal cap cells than in
Xenopus blastema cells and in particular they were not
u p r e g u l a t e du p o na m p u t a t i o ni nl i m bb l a s t e m ac e l l s
compared to non-regenerating limbs. One notable dif-
ference though is, that oct91 was found to be more
highly expressed in animal cap cells, but similarly was
not expressed or very lowly expressed in blastema cells.
T h ed i f f e r e n c em i g h to r i g i n a t ef r o mas u b o p t i m a lp r i -
mer set used in qPCR analysis.
The zebrafish caudal fin qPCR results too, were in
agreement with published microarray data from regener-
ating adult fins. Generally the stem cell markers were
expressed both in regenerating and non-regenerating
fins and none was upregulated in blastema cells, while
the relative expression of blastema markers was higher
in regenerating adult fins [35]. This confirms that our
qPCR results represent the general trend.
Spatial expression pattern of pluripotency associated
stem cell markers
For function, not only absolute expression level but also
spatial distribution of a factor matters. Therefore, we
investigated the spatial expression of some of the repro-
gramming and pluripotency associated factors in Xeno-
pus looking at the expression patterns of the three
factors that showed the highest absolute real time
expression (sox2, c-myc and sall4).
In situ hybridization revealed that c-myc was most
highly expressed in the non-regenerating Xenopus tail
and the tail blastema where it spread over the whole of
the regeneration bud, including notochord, neural tube
and mesenchyme (Figure 2D). The expression in the
developing (Figure 2A) and regenerating limb bud (Fig-
ure 2A’-2A"’ was much lower and diffusely spread over
the whole limb bud, which matched with the qPCR
result where expression was four times lower in the
limb bud than in 3 dpa tail blastema.
The expression pattern of sall4 in developing and
regenerating limb buds has been published previously
[36] and is included here because it is one of the most
highly expressed pluripotency associated genes in regen-
eration blastemas.
We found sall4 was localised to the distal mesench-
yme of the developing st52 limb bud (Figure 2B) and
was also strongly expressed in the mesenchyme of the
regenerating limb (Figure 2B’-2B"’), which was in agree-
ment with the published expression pattern. In the
regeneration bud of the tail sall4 was mainly localized
to the distal tip (Figure 2E).
In contrast, sox2 showed a very distinct localization to
a posterior region in the developing limb bud just proxi-
mal to the amputation plane (Figure 2C). In the regen-
erating limb sox2 seemed still confined to the same
region in the distal stump and showed little or no
expression in the blastema itself (Figure 2C’-2C"’). Dur-
ing collection of blastemas for qPCR this distal stump
region was included since dedifferentiation is thought to
happen in this distal zone.
During tail regeneration sox2 expression was confined
to the neural tube (Figure 2F).
The diffuse expression pattern seen for c-myc and
sall4 is compatible with a model where c-myc and sall4
induce or facilitate dedifferentiation of the stump tissue
and keep the cells in a less differentiated state. However,
the localised expression pattern seen for sox2 points
more towards a role in the development of a specific tis-
sue or cell type in the neural tube and limb bud.
Cell cycle analysis in regenerating and non-regenerating
fin cells versus embryonic cells
Embryonic stem cells differ markedly from other cells in
their cell cycle profile and regulation. It has been shown
that ES cells and other pluripotent cells have much
shorter gap phases (G1 and G2) or lack them altogether.
These particular cell cycle properties of ES cells have
been connected with pluripotency maintenance [37]. To
compare cell cycle profiles of pluripotent blastomere
cells and fin blastema cells, we performed a FACS analy-
sis of their cell cycle.
Cell survival after blastomere and blastemal cell recov-
ery was high in all samples, ranging from 90% to 98%
(Figure 3A). In all samples most of the cells were in G0/
G1. The percentage of cells in G2/Mitosis (G2/M) was
quite similar in the non-regenerating fin (t = 0 hours
post amputation (hpa)), early regenerating fin (48 hpa
blastema) and in the embryo (9.3%, 10.6% and 10.14%
respectively) but higher in 4 dpa blastema cells (17.2%)
where regenerative outgrowth is at its highest (Figure
3B, 3C and 3D).
While FACS profile of cells showed similar percentage
of cells in G2/M at 0 hpa and 48 hpa, specific differ-
ences were observed in pH3 expression in localized
zones when 0 hpa cells and 48 hpa blastemal cells were
compared (Additional file 2) showing that cells in the
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regenerating fin. On the other hand, histograms from
flow cytometric analysis of Hoechst-stained cells did not
show similarities between FACS cell profile in embryos
and in the regenerating fin (data not shown) indicating
that blastemal cells are controlled by a somatic cell
cycle and do not revert to an embryonic one.
Knockdown of either pou5f1 or sox2 impairs fin
regeneration
Having shown the presence of the reprogramming fac-
tors, we wanted to test whether they were necessary for
regeneration. To test for functionality we carried out a
morpholino knockdown in the zebrafish caudal fin using
two published morpholinos which had been tested in
the embryo for specificity and function. We chose to
use morpholino 1 (from now on called pou MO) against
the pou5f1 gene [38]. Pou MO has been shown to phe-
nocopy the mutant strain spiel-ohne-grenzen (spg),
which has a mutation in the pou5f1 gene. The sox2 MO
has been previously tested during retina pattern forma-
tion in zebrafish [39]. Since we did not know what phe-
notypes to expect for pou MO and sox2 MO injected
fin blastemas, we used msxb morpholino, which has a
published phenotype in fin regeneration as a positive
control. The homeobox gene msxb,af r e q u e n t l yu s e d
blastema marker, has been shown to be indispensable
for blastema growth with a morpholino knockdown
method [40]. If we were able to replicate the published
msxb MO phenotype in the fin then we could have con-
fidence in the phenotype from the pou MO and sox2
MO.
As a control for unspecific phenotypes induced by
injection we injected the lineage tracer dextran and a
p o uM Ow i t hf i v em i s m a t c h e s( p o u5 - m i sM O ) .A s
expected neither dextran nor pou 5-mis MO had an
effect on fin outgrowth (Figure 4A and 4G (The increase
in dorsal regrowth seen with pou 5-mis MO is not sig-
nificant)). Our positive control, msxb MO, injected into
a 3 dpa blastema inhibited fin regeneration to a similar
extent as previously published [40] (Figure 4B and 4G).
When pou MO and sox2 MO were injected into the
dorsal 3 dpa fin blastema an impairment of regeneration
was observed in the dorsal fin (Figure 4C and 4D).
While msxb MO reduced overall regrowth in the dorsal
fin to 77% of ventral fin regrowth, pou MO and sox2
MO reduced dorsal regrowth over four days to 78% and
87%, respectively. However, if regrowth was calculated
for the last 24 h only, when morpholino was actively
present, the inhibition was much more pronounced,
with dorsal regrowth down to 22%, 33% and 58% for
msxb MO, pou MO and sox2 MO, respectively. This
demonstrates that both pou5f1 and sox2 are not only
Figure 2 In situ hybridization of c-myc, sall4 and sox2 in developing and regenerating limbs and tails. A-A"’) Expression of c-myc in
developing st52 limbs (A) and amputated limbs at 0 dpa, 1 dpa and 3 dpa (A’-A"’). c-myc expression is diffuse and very weak in the developing
limb bud and the blastema. B-B"’) Expression of sall4 in developing st52 (B) and regenerating limbs at 0 dpa, 1 dpa, 3 dpa (B’-B"’). sall4 is
expressed diffusely in the distal mesenchyme of the developing limb bud and after amputation in the whole of the blastema. C-C"’) Expression
of sox2 in developing (C) and regenerating (C’-C"’) limbs. sox2 is expressed proximal to the blastema in the posterior mesenchyme. D) c-myc
mRNA is expressed in the entire regeneration bud of a 3 dpa tail and is much stronger than in limbs. E) sall4 mRNA expression in 3 dpa tail is
mainly seen in the distal tip of the regenerating tail. F) sox2 mRNA expression in 3 dpa tail is confined to the neural tube. (dpa = days post
amputation). Thin black line indicates amputation plane
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eration at 3 dpa (Figure 4H).
Injection of msxb MO only showed a significant reduc-
tion of fin outgrowth if injected into a 3 dpa blastema in
accordance with the observed increase in msxb expres-
sion around that time as detected by qPCR or in situ
hybridization [41]. Reasoning that the reprogramming
factors pou5f1 and sox2 might be already needed at an
earlier time point during fin regeneration we injected
morpholino at different times during blastema formation
and regrowth. Injection of morpholino into 0 dpa fins
had no effect on regeneration, though for technical rea-
sons we were only able to inject much lower volumes
than into blastemas themselves. Injection of sox2 MO
into a 1 dpa regenerating fin also did not lead to a pheno-
type (Figure 4F and 4I). However, pou MO injected into
1 dpa blastema inhibited dorsal fin outgrowth by 40%. If
morpholinos were injected into 2 dpa fin blastemas again
pou MO but not sox2 MO reduced fin outgrowth by a
similar extent as at 1 dpa (Figure 4E, 4F and 4I).
So while msxb and sox2 a r eo n l yn e e d e df o rf i n
regrowth at three days post amputation, pou5f1 has an
additional function during the formation and outgrowth
of the early blastema.
T os e ei ft h er e d u c t i o ni nr e g r o w t hw a sd u et oc e l l
death we performed terminal deoxynucleotidyl transfer-
ase-mediated dUTP nick end labeling (TUNEL) staining
24 h after injecting pou MO into 2 dpa fin blastemas to
visualise dying cells. A count of defined areas of four
different fins revealed no difference in numbers of dying
cells between the dorsal and the ventral fin (Figure 4J).
In contrast, when we analysed cell proliferation by pH3
immunostaining in 4 dpa fin blastemas injected with
pou MO 24 h earlier, we could see a clear and signifi-
cant reduction (P ≤ 0.05) in cell divisions in the dorsal
fin in three out of four fins (Figure 4J). The difference
between dorsal and ventral cell divisions is not as big as
expected because pH3 immunostaining only marks
actively dividing cells at one particular time point.
Furthermore dorsal outgrowth seems to recover over
Figure 3 Cell cycle analysis. (A) Cell survival after blastomere and blastemal cell recovery at different time points (0 h, 48 h and 4 d). (B)
Representation of cells in G0/G1 (blue) and G2/M (red) cell cycle phases. Results are expressed as percentages. FACS histogram of non-
regenerating (C) and 4 dpa regenerating fin blastema cells (D). Cells in G0/G1 are included in R9 and G2/M in area R10.
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Page 7 of 14time since dorsal and ventral regrowth differences
become less pronounced 48 h after MO injection.
Discussion
Restricted dedifferentiation of blastema cells
Appendage regeneration is a complex biological process
that takes place only in a few lower vertebrates like tele-
ost fish and some amphibians. A key step in the replace-
ment of the lost appendage is the formation of the
blastema, a transient structure of undifferentiated and
proliferating cells which gives rise to all the different
cell types in the newly formed appendage. However,
how exactly blastema formation is achieved is still
unknown. The idea that the process of dedifferentiation
of fibroblast cells to iPS cells and dedifferentiation dur-
ing in vivo regeneration is regulated by a similar
mechanism is attractive but unexplored.
For that reason, expression profiles of pluripotency
associated factors in blastemal cells were compared with
expression profiles in pluripotent embryonic reference
cells. A hallmark of vertebrate epimorphic regeneration
is the re-activation of genes that are active during
Figure 4 Morpholino injection into zebrafish caudal fins. A-D) Bright field and fluorescence picture of a dextran (A) msxb MO (B) pou MO
(C) and sox2 MO (D) injected and electroporated fin: injections were done into the dorsal half of a 3 dpa blastema and photographed 24 h
later. E, F) Time course for pou MO (E) and sox2 MO (F) injected and electroporated fins at 3 dpa, 2 dpa, 1 dpa and 0 dpa. Pictures were taken
24 h after injection. G-I) Percentage of dorsal versus ventral fin outgrowth (in green) and average inhibition of dorsal versus ventral fin (in red) of
fins which were injected 3 dpa (G, H) and on day 0 to 3 pa as indicated (I). (see Method for exact calculation) (Asterisk indicate significant
difference (P < 0.5) compared to dextran or pou 5-mis MO control or for 1 dpa injected fins between pou MO and sox2 MO injected fins). J)
Measurement of apoptosis and cell proliferation in pou MO injected fins. There is no significant difference between dorsal and ventral fins in
apoptosis as measured by TUNEL while there is a significant reduction of cell divisions in the dorsal fin as measured by pH3 staining (P ≤ 0.05).
Black lines indicate blastema size on day of injection. Error bars indicate standard error.
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tema cells became pluripotent they would reactivate or
upregulate the genes which are part of the pluripotency
network, as is seen for iPS cells [25-27].
However, we found that blastemal cells had little in
common with our pluripotent reference cells. Blastema
cells neither upregulated any of the key transcription
factors needed for induction of iPS cells (pou5f1, sox2,
c-myc, klf4) as would be expected if they became pluri-
potent nor did they significantly upregulate many of the
other transcription factors needed for self-renewal in
iPS cells. Furthermore, hierarchical clustering of the
published global gene expression data for Xenopus ani-
mal cap cells and blastema cells [43-45] demonstrated
that they exhibit a different expression pattern, that is,
blastema cells clustered on a different tree branch than
pluripotent cells (data not shown). In other aspects as
well, blastema cells were distinct from pluripotent cells.
The analyses of the cell cycle showed that blastema cells
have all the characteristics of somatic cells and cycle
more slowly than pluripotent stem cells.
Furthermore, evaluation of the expression pattern of
the three most highly expressed genes during Xenopus
regeneration in the qPCR analysis revealed that one is
not expressed uniformly in the blastema as would be
expected if it had a role in conferring or maintaining
pluripotency in these cells. This evidence suggests that
blastema cells are not pluripotent but at best only multi-
potent. A similar conclusion was reached for newt blas-
tema cells since neither oct4 nor nanog,t w oo ft h e
central factors in the network conferring pluripotency to
iPS cells, were expressed [12]. Additionally, a recently
published paper implies that blastema cells have less dif-
ferentiation potential than thought [5]. Kragl et al. (2009)
reported that the regeneration blastema in Axolotl is a
pool of heterogeneous progenitor cells with restricted
developmental potential, despite the rather uniform and
undifferentiated appearance of blastema cells. By labelling
specific tissues with embryonic tissue grafts marked with
green fluorescent protein they could show that each tis-
sue produces its own progenitor cells. These progenitors
do not cross tissue boundaries during regeneration but
only regenerate its own tissue type, so muscle regenerates
muscle and cartilage regenerates cartilage, with the only
exception of dermis which is able to make cartilage and
dermis but not muscle. In accordance, a recent proteo-
mics analysis of regenerating Xenopus limb buds revealed
a significant number of upregulated proteins in blastema
cells are also found in one or more adult stem cell types
[46]. Whether this means that mature cell types dediffer-
entiate to become more like adult stem cells or whether
resident adult stem cells are activated to produce blas-
tema cells with hallmarks of the cells of origin is unclear
at the moment.
Possible mechanism and function
Despite the evidence that blastema cells are not pluripo-
tent there are some strong similarities between blastema
cells and iPS cells. Blastema cells and their precursors
express low levels of some or all of the key factors
needed for reprogramming to iPS cells. We hypothesise
that these low levels are sufficient to trigger a similar
mechanism to reprogramming which then gets stalled in
an early, partially reprogrammed state leading to a cell
which is only multipotent. Such intermediate states are
frequently found during reprogramming among iPS
colonies. Some inroads have been made in deciphering
the mechanism of reprogramming by analysing this/
these intermediate state/s (see review: [47]).
The process of reprogramming is slow and takes one
to two weeks. Some of the earliest markers that are
upregulated during this process are alkaline phosphatase
(AP) and SSEA1. The SSEA1 expressing cells then acti-
vate other pluripotency associated genes like Oct4, Sox2,
Nanog and Tert only late in the process. The two early
markers (AP and Fut1, homologue of ssea1)a r ea l s o
either expressed or upregulated during blastema forma-
tion in Xenopus (not shown and Figure 1). Therefore it
is plausible that these two genes might function in a
similar way during dedifferentiation and blastema for-
mation as during reprogramming by facilitating the
action of the later factors.
In zebrafish, none of the pluripotency associated mar-
kers tested are completely shut off in the adult fin. Simi-
larly in Xenopus seven of the 11 genes looked at are
already expressed in the developing limb bud or tail.
Avoiding a complete shutdown of gene expression should
facilitate reactivation or reemployment of these factors
later on, for example, during regeneration. Here we
showed that these factors are indeed not just present but
also required for regeneration. A knockdown of pou5f1
with a gene specific morpholino impaired fin regrowth at
various time points during regeneration. And likewise a
second gene, sox2 was also necessary for regeneration
b u tt oal e s s e re x t e n t .F r o mt h e s er e s u l t sw ec o n c l u d e
that, despite pou5f1 expression in zebrafish regenerating
fin not reaching levels of a pluripotent cell, this gene is
crucial for fin regeneration from the very early stages of
regeneration onwards. At this stage, however, we can
only speculate what that function is, either during regen-
eration or in the adult fin. It has been shown that the
function of Pou5 proteins is conserved between mouse
and Xenopus and that they regulate similar genes in ES
cells and early Xenopus embryos [20]. The authors con-
cluded that the ability of Oct4 to maintain ES cell pluri-
potency is derived from the ancestral function of this
class of proteins to maintain multipotency during early
vertebrate development. It is reasonable to assume that
the low level of pou5f1 expression during regeneration is
Christen et al. BMC Biology 2010, 8:5
http://www.biomedcentral.com/1741-7007/8/5
Page 9 of 14not enough to confer real pluripotency reverting the blas-
tema cells to a completely reprogrammed state, however,
that a synergistic effect of pou5f1 together with other
pluripotency genes, could enable these cells to dediffer-
entiate and provide them with the multipotency required
to give rise to certain cell types, allowing the reconstitu-
tion of the lost structure. However, while pou5f1/oct4 is
required for fin regeneration, it does not seem to be
essential for blastema formation in general, since neither
Xenopus nor newt reactivate pou5f1/oct4 homologue
expression in the blastema [12]. But then again repro-
gramming of neural stem cells has also been achieved
without Oct4 as one of the reprogramming factors indi-
cating that reprogramming can be successful without
exogenous Oct4 [48].
In contrast to what was observed for pou5f1, sox2
seems to be mainly required for regenerative outgrowth
similarly to what has been observed for msxb.T a k i n g
the expression pattern of sox2 in limb and tail blastema
and its role in fin outgrowth into account we speculate
that sox2 could have a role in specifying early neural
precursor cells that contribute to the innervation of the
regenerate. A role for sox2 in neurogenesis has been
previously described in other species [49,50] and in
mouse ES cells [51]. Furthermore, in a previous in vitro
study we observed that sox2 is expressed in blastula cell
colonies that will subsequently give rise to neuronal pre-
cursors (unpublished results). Additionally, limb and fin
blastema outgrowth requires innervation to proliferate
and replace structures [52-55].
Research into the mechanism behind reprogramming
also demonstrated that the presence of the reprogram-
ming factors alone was not sufficient for success since
secondary iPS cells harbouring dox-inducible transgenes
were only induced at a rate of 2% [56,57]. There are sev-
eral lines of evidence that a correct stoichiometric mix-
ture of the reprogramming factors is necessary for
successful reprogramming and that more is not necessa-
rily better. Leaving some of the factors out of the repro-
gramming cocktail can increase iPS efficiency in cells
with expression of these factors [58]. Others have found
that in an all-in-one vector approach, the sequence of
the factors is important, again pointing towards the
importance of delivering the correct relative level for
each reprogramming factor. This could explain why low
levels of the pluripotency associated factors might be
sufficient to start the dedifferentiation/reprogramming
process during blastema formation if the stoichiometric
requirement is fulfilled. Furthermore, it could also
account for why older, non-regenerating Xenopus limbs
will not initiate blastema formation despite expressing
the same factors but at different and ineffective stoichio-
metric combination.
Conclusions
Knocking down the expression of pou5f1/oct4 and sox2
with morpholinos resulted in an impairment of regen-
eration, indicating that, despite the low expression
levels, these factors do have a functional role during epi-
morphic regeneration. In the light of this functional evi-
dence we make an associative link between partially
reprogrammed iPS cells and the half way state of blas-
tema cells and suggest that the processes leading to
these two cell types might be regulated by some com-
mon mechanisms.
Methods
Animal maintenance
Zebrafish (AB strain) were maintained in tanks with
recirculating water system under standard conditions
[59]. Xenopus laevis tadpoles were kept in a recirculat-
ing system at 23°C and fed twice a day until the
required stage [60].
Embryo collection and blastema recovery
Zebrafish embryos were washed for two minutes with a
0.5% bleach solution, rinsed twice with embryo medium
(EM) and kept in fresh EM at 28°C until they reached
the oblong stage (3 2/3 h) [61].
For blastema recovery, fish were anaesthetized in tri-
cain, caudal fins were partially amputated and animals
were then kept in system tank until sample recovery.
Samples were recovered at different times: 0 hours post-
amputation (hpa), 6 hpa (when a thin layer of wound
epidermis appears), 24 hpa (wound epidermis), 48 hpa
(functional blastema), 3 dpa and 4 dpa. Fin samples
from six animals were pooled for each replicate and
four to seven replicates have been done.
For Xenopus animal caps, embryos were obtained by
artificial fertilization and cultured in 0.1 Modified
Barth’s Saline (MBS) until stage 9 at which point 20 ani-
mal caps were excised and pooled for RNA extraction.
For tail and limb transections tadpoles were anaesthe-
tized in 1/3000 MS222 in 0.1 × MMR and transferred
to a moistened paper towel. For tail amputations, the
posterior 50% of the tail was removed with iridectomy
scissors. Limbs (st52 or st57) were amputated bilaterally
at mid zeugopod level. After amputation tadpoles were
let to recover in 0.1 × MMR and kept and fed in the lab
in individual tanks till blastema recovery. Blastemas
(including about 200 μm of the distal stump tissue) of
20 tadpoles each were recovered at 0 dpa, 1 dpa, 3 dpa
and 5 dpa and pooled for RNA extraction. Two to three
replicas have been done for each time point.
RNA extraction and cDNA Synthesis
Total RNA was extracted from zebrafish embryos, cap
cells or blastemas using TRIZOL® method according to
the manufacturer’s guidelines (Invitrogen S.A., Barcelona,
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Drop spectrophotometer (ND-1000) and 0,2-1 μgt o t a l
RNA was used for reverse transcription in a 20 μlm i x -
ture containing 1 μlo f5 0μM Oligo(dT) primer, 2 μl1 0
mM dNTP Mix, 4 μl 5× cDNA synthesis Buffer, 1 μl0 , 1
MDTT, 1 μl RnaseOUT, 1 μl Cloned AMV RT (15 units/
μl) (Invitrogen S.A, Barcelona, Spain) and DEPC-treated
water to 20 μl. The reverse transcription was conducted
at 50°C for 50 minutes and 85°C for five minutes, and
samples were stored at -20°C until use. A pool of 100
embryos was used for each replicate
Real-Time quantitative PCR
PCR products were detected by measuring the increase
in fluorescence caused by the binding of SYBR GREEN
dye (Invitrogen, 11760-500) to dsDNA in the reaction
tube. For zebrafish 10 μl SYBR were added to 6 μl
water, 2 μl sample and 1 μl of each primer (10 μM). For
Xenopus the cDNA was diluted 1:25 first and then 5 μl
o ft h ed i l u t i o nw e r ec o m b i n e dw i t h3μl of water and 1
μlo fe a c hp r i m e r( 1 0μM) before 10 μlS Y B Rg r e e n
were added. The primers were designed by using the
Primer Express (v.3.0) Software from Applied Biosys-
tems Foster City, CA, USA. Primer pairs were chosen to
minimize dimerization and to be situated as far as possi-
ble towards the 3’ end of the mRNA. Relative expression
of the PCR products was determined by using the ΔΔCt
method [62,63] using as housekeeping gene rpl13A
(Zebrafish) or ornithine decarboxylase (ODC) (Xenopus)
and then normalizing against the highest expression.
Each sample was run in duplicate to triplicate and the
mean Ct was used in the equation. The primer sets used
are shown in Table 1.
Flow cytometry analysis
For cell cycle analysis, cells were incubated at 37°C for
30 minutes using Hoechst 33342 (H342 - SIGMA,
Madrid, Spain) (10 μg/ml final concentration). The
tubes were cooled on ice and cells were pelleted by cen-
trifugation (200 g, 5 minutes). The supernatant was
removed and cells were resuspended in 0.5 ml of PBS
(4°C).
Propidium Iodide (PI - SIGMA, Madrid, Spain) was
added at 4 μg/mL (final concentration) to detect dead
cells. Immediately after, samples were acquired in a
Moflo cell sorter (DakoCytomation (Fort Collins, CO,
USA)) adjusted for both UV (351 nm) and blue (488
nm) excitation lines for the detection of H342 (450/65)
and PI (670/30) fluorescence respectively. All analyses
were performed applying Summit software DakoCyto-
mation (Fort Collins, CO, USA).
Re-analysis of microarray data sets
Microarray data are available at the NCBI Gene Expres-
sion Omnibus database under the following accession
numbers: Xenopus animal cap - GSE3334 (Dickinson et
al., 2006), GSE8990, GSE8496, Xenopus regenerating
hindlimb - GSE9813 (Pearl et al., 2008), GSE4738 (Grow
et al., 2006), zebrafish caudal fin adult - GSE3667 [35],
zebrafish caudal fin larval - GSE10184, zebrafish caudal
fin adult/larval - GSE10188.
Microarray data was normalized independently for
each experiment using GC-RMA in R statistical software
http://www.r-project.org. Then for each gene in each
sample a relative expression was calculated using a per-
cent rank. It is defined as a rank of the value in a data-
set as a percentage of the dataset, and evaluates the
relative standing of a value within a dataset. The percent
ranks of the genes of interest were obtained from
respective probes in each dataset.
The hierarchical clustering was performed using hclust
function with the average method in R software.
Immunohistochemistry
For cell division and apoptosis detection, fins were fixed
( w i t hP F A4 %f o r2ha t4 ° C )a n du s e da sw h o l em o u n t s .
Fins were first washed three times in Tris buffered saline
(TBS) for 10 minutes before they were permeabelised in
TBS plus 0.02% Triton and 0.05% tween-20 for 30 min-
utes at RT. They were than washed twice in TBS for five
minutes, incubated in 10 mM Tris-HCl plus 5 mM
EDTA at pH 8.5 for 10 minutes before proteinase K trea-
ted (20 μg/ml) in the same Tris buffer as before for 15
minutes. Two washes in 5 mM EDTA for five minutes
were followed by incubation in the TdT buffer pH7.75
for 10 minutes to equilibrate for the TUNEL reaction.
For the TUNEL reaction (2 h at 37°C) the in situ Cell
death detection kit TMR red from Roche Diagnostics,
Barcelona, Spain was used according to manufacturer’s
instruction with an enhancement step of the signal. To
stop the reaction, fins were washed in Saline-sodium
citrate (SSC) plus EDTA buffer twice for 10 minutes, fol-
lowed by two washes in TBS for 10 minutes. Fins were
blocked in TBS plus 6% donkey serum twice for 10 min-
utes and then incubated in biotinylated anti-rodamin
(1:20) and anti-pH3 (1:500) antibody (rat, Sigma) over-
night at 4°C. Next day fins were washed extensively in
TBS plus serum before incubated in secondary antibody
(Strepdavidine-Alexa568, 1:400; and anti-rat IgG-Cy5,
1:100) overnight at 4°C. Finally samples were washed in
TBS, exposed to Dapi for five minutes and mounted to
be examined as previously described.
In situ hybridization
The following clones were ordered from ImaGene
http://www.imagenes-bio.de: sall4: IRBHp990H1244D, c-
myc: IRBHp990A0223D and sox2: IRBHp990B0144D. In
situ hybridization was done as described in [64]. To
make in situ probes sall4 pCMV Sport6 was cut with
EcoRV and transcribed with polymerase T7 to make
antisense probe and cut with BamHI and transcribed
with Sp6 polymerase to make sense probe. C-myc anti-
sense probe was done cutting c-myc pCMV-Sport6.ccdb
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was cut with XhoI and transcribed with Sp6. Sox2-
pCMV-Sport6 was cut with BamHI to make either anti-
sense or sense probe and transcribed with T7 or Sp6,
respectively.
MO microinjection and in vivo electroporation
MO microinjection and electroporation was essentially
done as in [40] with a few modifications. Fish were
anesthetized with tricaine as previously described and
one of 4 MO (GeneTools, Inc. Philomath, OR, USA)
was injected into the dorsal side of a 0 to 3 dpa fin blas-
tema grown at 28°C. Immediately after the injection of
the blastema distal to each dorsal bony ray with MO,
the whole fin was electroporated using a CUY21 Square
Wave Electroporator and CUY647-5 × 10 tweezer elec-
trodes (Nepa Gene Co, Ldt, Japan). We used the same
parameters as Thummel et al.; with 10 consecutive 50
msec pulses at 15V with a one second pause between
pulses and an approximately 2 mm gap between the
tweezer electrodes. As conducting gel we used 3%
methylcellulose. Each fish was tracked individually to
calculate the regeneration progress over time. Zebrafish
fins were imaged just after MO injection/electroporation
and again 24 h later. The area of both dorsal and ventral
regrowth was measured using the MetaMorph office
programme (Molecular Devices Corporation, USA). Per-
centage of overall fin regrowth was determined as (D/V)
x100 (where D is dorsal blastema and V is ventral blas-
tema 24 h after MO injection). Growth over the last 24
h was calculated by (Dx-D(x-1))×100/(Vx-V(x-1))
(where Dx is dorsal blastema at day x and D(x-1) is dor-
sal blastema on the day before, Vx is ventral blastema at
day x and V(x-1) is ventral blastema on day before,
making sure that D(x-1) and V(x-1) (dorsal and ventral
blastema on day of morpholino injection) are of equal
size. N = 5 for dextran 2d, n > 20 for pou MO 3d, n =
8 to 12 for rest.
Morpholinos used are: msxb MO; TTAAC-
CATCCGCCACGAGCTGCTGC, pou MO;
CGCTCTCTCCGTCATCTTTCCGCTA, pou 5-mis
MO, CGGTCTGTCCGTGATCTTTGCGGTA, sox2
MO; GCTCGGTTTCCATCATGTTATACA. Each mor-
pholino contained a 3’fluorescein tag and was resus-
pended as a 2 mM solution in water and either injected
at 1.2 mM (msxb MO) or 2 mM (sox2 MO, pou MO,
pou 5-mis MO).
Statistical analysis
In zebrafish, qPCR data were analyzed with SPSS soft-
ware (SPSS Inc., Chicago, IL, USA) (SPSS Statistics 17.0)
using a repeated measures linear mixed-effect model
(LME) to test the significance of changes in gene
expression. Oblong stage (for pluripotency associated
markers) and 48 hpa (for blastema markers) were used
as intercept for the models, whereas replicates were
used as a grouping factor (random effect). Results in
Additional file 1 show the expression effect size at each
time point (mean+-SEM) compared to oblong stage and
48 hpa, respectively. For verifying Xenopus qPCR or the
morpholino knockdown results a student t-test was
performed.
Animal Welfare
All animal experiments were done with the approval of
the institutions ethical committee.
Additional file 1: Figure S1: Statistical relevance of changes in
expression levels. Effect sizes (mean ± error) for each regeneration time
point on the intercept, for zebrafish pluripotency associated makers and
blastema markers. Oblong stage (for pluripotency markers) and 48 hpa
(for blastema markers) were the intercept of the models. Asterisks
represent statistical differences with the intercept.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1741-7007-8-5-
S1.PDF]
Additional file 2: Figure S2: Cell divisions in non- regenerating and
regenerating fin. Immunohistochemistry of phospho-Histone H3
localization in zebrafish fins: 0 hours (A) and 48 hours (B) post
amputation.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1741-7007-8-5-
S2.PDF]
Abbreviations
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mediated dUTP nick end labelling.
Acknowledgements
We thank Carme Fabregat, Dr. Mercé Martí, Dr. Filipe Martinez-Pastor, José
Miguel Vaquero, Lola Mulero, Cristina Pardo and Cristina Morera for technical
assistance. This work was partially supported by grants from Ramón y Cajal
Program RYC-2008-02339 (VR), Fondo de Investigaciones Sanitarias (TERCEL,
PI052847), Marató de TV3, MICINN, Fundación Cellex, The G. Harold and Leila
Y. Mathers Charitable Foundation and Ipsen Foundation.
Author details
1Center for Regenerative Medicine of Barcelona, 08003 Barcelona, Spain.
2Gene Expression Laboratory, The Salk Institute for Biological Studies, La
Jolla, California 92037, USA.
3Current address: INDEGSAL, University of León,
24071 León, Spain.
4Current address: Department of Molecular Biology,
University of León, 24071, León, Spain.
Authors’ contributions
BC participated in design of the study, collected all the Xenopus data,
participated in the collection and interpretation of morpholino knockdown
and drafted the manuscript. VR participated in design of the study, collected
and interpreted all zebrafish qPCR data, collection and interpretation of
FACS results, participated in setting up and interpretation of morpholino
knockdown and drafted the manuscript. MR helped with design of study,
participated in morpholino knockdown study and helped with manuscript.
IP provided data analysis and interpretation of microarray reanalysis and
helped with manuscript. JCIB participated in design of the study, financial
support and helped with manuscript writing.
Received: 15 October 2009
Accepted: 20 January 2010 Published: 20 January 2010
Christen et al. BMC Biology 2010, 8:5
http://www.biomedcentral.com/1741-7007/8/5
Page 12 of 14References
1. Satoh A, Bryant SV, Gardiner DM: Regulation of dermal fibroblast
dedifferentiation and redifferentiation during wound healing and limb
regeneration in the Axolotl. Development, Growth & Differentiation 2008,
50:743-754.
2. Satoh A, Graham GM, Bryant SV, Gardiner DM: Neurotrophic regulation of
epidermal dedifferentiation during wound healing and limb
regeneration in the axolotl (Ambystoma mexicanum). Dev Biol 2008,
319:321-335.
3. Echeverri K, Clarke JD, Tanaka EM: In Vivo Imaging Indicates Muscle Fiber
Dedifferentiation Is a Major Contributor to the Regenerating Tail
Blastema. Developmental Biology 2001, 236:151-164.
4. Morrison JI, Loof S, He P, Simon A: Salamander limb regeneration involves
the activation of a multipotent skeletal muscle satellite cell population.
The Journal of Cell Biology 2006, 172:433-440.
5. Kragl M, Knapp D, Nacu E, Khattak S, Maden M, Epperlein HH, Tanaka EM:
Cells keep a memory of their tissue origin during axolotl limb
regeneration. Nature 2009, 460:60-65.
6. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse
embryonic and adult fibroblast cultures by defined factors. Cell 2006,
126:663-676.
7. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R,
Bilić J, Pekarik V, Tiscornia G, Edel M, Boué S, Izpisúa Belmonte JC: Efficient
and rapid generation of induced pluripotent stem cells from human
keratinocytes. Nat Biotechnol 2008, 26:1276-1284.
8. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S,
Muhlestein W, Melton DA: Induction of pluripotent stem cells from
primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008,
26:1269-1275.
9. Kim JB, Sebastiano V, Wu G, Araúzo-Bravo MJ, Sasse P, Gentile L, Ko K,
Ruau D, Ehrich M, Boom van den D, Meyer J, Hübner K, Bernemann C,
Ortmeier C, Zenke M, Fleischmann BK, Zaehres H, Schöler HR: Oct4-induced
pluripotency in adult neural stem cells. Cell 2009, 136:411-419.
10. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD,
Ng K, Daley GQ: Generation of induced pluripotent stem cells from
human blood. Blood 2009, 113:5476-5479.
11. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K,
Yamanaka S: Induction of pluripotent stem cells from adult human
fibroblasts by defined factors. Cell 2007, 131:861-872.
12. Maki N, Suetsugu-Maki R, Tarui H, Agata K, Del Rio-Tsonis K, Tsonis PA:
Expression of stem cell pluripotency factors during regeneration in
newts. Dev Dyn 2009, 238:1613-1616.
13. Lin G, Slack JM: Requirement for Wnt and FGF signaling in Xenopus
tadpole tail regeneration. Dev Biol 2008, 316:323-335.
14. Poss KD, Shen J, Nechiporuk A, McMahon G, Thisse B, Thisse C, Keating MT:
Roles for Fgf signaling during zebrafish fin regeneration. Dev Biol 2000,
222:347-358.
15. Stoick-Cooper CL, Weidinger G, Riehle KJ, Hubbert C, Major MB, Fausto N,
Moon RT: Distinct Wnt signaling pathways have opposing roles in
appendage regeneration. Development 2007, 134:479-489.
16. Whitehead GG, Makino S, Lien CL, Keating MT: fgf20 is essential for
initiating zebrafish fin regeneration. Science 2005, 310:1957-1960.
17. Yokoyama H, Ogino H, Stoick-Cooper CL, Grainger RM, Moon RT: Wnt/beta-
catenin signaling has an essential role in the initiation of limb
regeneration. Dev Biol 2007, 306:170-178.
18. Kawakami Y, Rodriguez Esteban C, Raya M, Kawakami H, Marti M, Dubova I,
Izpisua Belmonte JC: Wnt/beta-catenin signaling regulates vertebrate
limb regeneration. Genes & Development 2006, 20:3232-3237.
19. Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O,
Wray J, Yamanaka S, Chambers I, Smith A: Nanog is the gateway to the
pluripotent ground state. Cell 2009, 138:722-737.
20. Morrison GM, Brickman JM: Conserved roles for Oct4 homologues in
maintaining multipotency during early vertebrate development.
Development 2006, 133:2011-2022.
21. Xing JG, Lee LE, Fan L, Collodi P, Holt SE, Bols NC: Initiation of a zebrafish
blastula cell line on rainbow trout stromal cells and subsequent
development under feeder-free conditions into a cell line, ZEB2J.
Zebrafish 2008, 5:49-63.
22. Ariizumi T, Takahashi S, Chan TC, Ito Y, Michiue T, Asashima M: Isolation
and differentiation of Xenopus animal cap cells. Current Protocols in Stem
Cell Biology 2009, Chapter 1, Unit 1D 5.
23. Sive HL, Grainger RM, Harland RM: Animal cap isolation from Xenopus
laevis. Cold Spring Harb Protoc 2007.
24. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP,
Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA,
Jaenisch R, Young RA: Core transcriptional regulatory circuitry in human
embryonic stem cells. Cell 2005, 122:947-956.
25. Rao S, Orkin SH: Unraveling the transcriptional network controlling ES
cell pluripotency. Genome Biology 2006, 7:230.
26. Orkin SH, Wang J, Kim J, Chu J, Rao S, Theunissen TW, Shen X,
Levasseur DN: The Transcriptional Network Controlling Pluripotency in ES
Cells. Cold Spring Harbor Symposia on Quantitative Biology 2008.
27. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH: A
protein interaction network for pluripotency of embryonic stem cells.
Nature 2006, 444:364-368.
28. Dent JN: Limb regeneration in larvae and metamorphosing individuals
of the South African clawed toad. Journal of Morphology 1962, 110:61-77.
29. Beck CW, Izpisua Belmonte JC, Christen B: Beyond early development:
Xenopus as an emerging model for the study of regenerative
mechanisms. Dev Dyn 2009, 238:1226-1248.
30. Beck CW, Christen B, Barker D, Slack JMW: Temporal requirement for bone
morphogenetic proteins in regeneration of the tail and limb of Xenopus
tadpoles. Mechanisms of Development 2006, 123:674-688.
31. Beck CW, Christen B, Slack JMW: Molecular Pathways Needed for
Regeneration of Spinal Cord and Muscle in a Vertebrate. Developmental
Cell 2003, 5:429-439.
32. Endo T, Tamura K, Ide H: Analysis of gene expressions during Xenopus
forelimb regeneration. Dev Biol 2000, 220:296-306.
33. Fan L, Crodian J, Liu X, Alestrom A, Alestrom P, Collodi P: Zebrafish
embryo cells remain pluripotent and germ-line competent for multiple
passages in culture. Zebrafish 2004, 1:21-26.
34. Lin S, Long W, Chen J, Hopkins N: Production of germ-line chimeras in
zebrafish by cell transplants from genetically pigmented to albino
embryos. Proceedings of the National Academy of Sciences of the United
States of America 1992, 89:4519-4523.
35. Andreasen EA, Mathew LK, Tanguay RL: Regenerative growth is impacted
by TCDD: gene expression analysis reveals extracellular matrix
modulation. Toxicol Sci 2006, 92:254-269.
36. Neff AW, King MW, Harty MW, Nguyen T, Calley J, Smith RC, Mescher AL:
Expression of Xenopus XlSALL4 during limb development and
regeneration. Dev Dyn 2005, 233:356-367.
37. Burdon T, Smith A, Savatier P: Signalling, cell cycle and pluripotency in
embryonic stem cells. Trends in Cell Biology 2002, 12:432-438.
38. Burgess S, Reim G, Chen W, Hopkins N, Brand M: The zebrafish spiel-ohne-
grenzen (spg) gene encodes the POU domain protein Pou2 related to
mammalian Oct4 and is essential for formation of the midbrain and
hindbrain, and for pre-gastrula morphogenesis. Development 2002,
129:905-916.
39. Pujic Z, Omori Y, Tsujikawa M, Thisse B, Thisse C, Malicki J: Reverse genetic
analysis of neurogenesis in the zebrafish retina. Dev Biol 2006,
293:330-347.
40. Thummel R, Bai S, Sarras MP Jr, Song P, McDermott J, Brewer J, Perry M,
Zhang X, Hyde DR, Godwin AR: Inhibition of zebrafish fin regeneration
using in vivo electroporation of morpholinos against fgfr1 and msxb.
Dev Dyn 2006, 235:336-346.
41. Akimenko MA, Johnson SL, Westerfield M, Ekker M: Differential induction
of four msx homeobox genes during fin development and regeneration
in zebrafish. Development 1995, 121:347-357.
42. Kizil C, Otto GW, Geisler R, Nusslein-Volhard C, Antos CL: Simplet controls
cell proliferation and gene transcription during zebrafish caudal fin
regeneration. Dev Biol 2009, 325:329-340.
43. Pearl EJ, Barker D, Day RC, Beck CW: Identification of genes associated
with regenerative success of Xenopus laevis hindlimbs. BMC
Developmental Biology 2008, 8:66.
44. Grow M, Neff AW, Mescher AL, King MW: Global analysis of gene
expression in Xenopus hindlimbs during stage-dependent complete and
incomplete regeneration. Dev Dyn 2006, 235:2667-2685.
45. Dickinson K, Leonard J, Baker JC: Genomic profiling of mixer and
Sox17beta targets during Xenopus endoderm development. Dev Dyn
2006, 235:368-381.
Christen et al. BMC Biology 2010, 8:5
http://www.biomedcentral.com/1741-7007/8/5
Page 13 of 1446. King MW, Neff AW, Mescher AL: Proteomics analysis of regenerating
amphibian limbs: changes during the onset of regeneration. The
International Journal of Developmental Biology 2009, 53:955-969.
47. Hochedlinger K, Plath K: Epigenetic reprogramming and induced
pluripotency. Development 2009, 136:509-523.
48. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S: A combined
chemical and genetic approach for the generation of induced
pluripotent stem cells. Cell Stem Cell 2008, 2:525-528.
49. Ferri AL, Cavallaro M, Braida D, Di Cristofano A, Canta A, Vezzani A,
Ottolenghi S, Pandolfi PP, Sala M, DeBiasi S, Nicolis SK: Sox2 deficiency
causes neurodegeneration and impaired neurogenesis in the adult
mouse brain. Development 2004, 131:3805-3819.
50. Pevny LH, Nicolis SK: Sox2 roles in neural stem cells. The International
Journal of Biochemistry & Cell Biology 2009.
51. Chen S, Choo AB, Nai-Dy W, Heng-Phon T, Oh SK: Knockdown of Oct-4 or
Sox-2 attenuates neurogenesis of mouse embryonic stem cells. Stem
Cells and Development 2007, 16:413-420.
52. Endo T, Bryant SV, Gardiner DM: A stepwise model system for limb
regeneration. Dev Biol 2004, 270:135-145.
53. Kumar A, Godwin JW, Gates PB, Garza-Garcia AA, Brockes JP: Molecular
basis for the nerve dependence of limb regeneration in an adult
vertebrate. Science 2007, 318:772-777.
54. Satoh A, James MA, Gardiner DM: The role of nerve signaling in limb
genesis and agenesis during axolotl limb regeneration. The Journal of
Bone and Joint Surgery 2009, 91:90-98.
55. Geraudie J, Singer M: Relation between nerve fiber number and pectoral
fin regeneration in the teleost. The Journal of Experimental Zoology 1977,
199:1-8.
56. Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R: A
drug-inducible system for direct reprogramming of human somatic cells
to pluripotency. Cell Stem Cell 2008, 3:346-353.
57. Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J,
Markoulaki S, Jaenisch R: A drug-inducible transgenic system for direct
reprogramming of multiple somatic cell types. Nat Biotechnol 2008,
26:916-924.
58. Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K: Reprogramming of
neural progenitor cells into induced pluripotent stem cells in the
absence of exogenous Sox2 expression. Stem Cells (Dayton, Ohio) 2008,
26:2467-2474.
59. Westerfield M: The Zebrafish Book. A Guide for the Laboratory Use of
Zebrafish (Danio rerio). Eugene, OR, University of OregonPress 1995, 385.
60. Nieuwkoop PD, Faber J: Normal table of Xenopus Laevis (Daudin). North-
Holland, Amsterdam 1967.
61. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF: Stages of
embryonic development of the zebrafish. Dev Dyn 1995, 203:253-310.
62. Gibson UE, Heid CA, Williams PM: A novel method for real time
quantitative RT-PCR. Genome Research 1996, 6:995-1001.
63. Winer J, Jung CK, Shackel I, Williams PM: Development and validation of
real-time quantitative reverse transcriptase-polymerase chain reaction
for monitoring gene expression in cardiac myocytes in vitro. Analytical
Biochemistry 1999, 270:41-49.
64. Pownall ME, Tucker AS, Slack JM, Isaacs HV: eFGF, Xcad3 and Hox genes
form a molecular pathway that establishes the anteroposterior axis in
Xenopus. Development 1996, 122:3881-3892.
doi:10.1186/1741-7007-8-5
Cite this article as: Christen et al.: Regeneration and reprogramming
compared. BMC Biology 2010 8:5.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Christen et al. BMC Biology 2010, 8:5
http://www.biomedcentral.com/1741-7007/8/5
Page 14 of 14